💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Karyopharm Therapeutics Inc. (KPTI)
« Back to company indexKPTI Chatter Timeline
Stock Ticker for KPTI
Most Active Tweeters for KPTI
| User | Tweets |
|---|---|
| @thomasmcdanie20 | 16 |
| @Biotech2050 | 15 |
| @Tickeron | 12 |
| @TranscriptDaily | 11 |
| @TheMarketsDaily | 11 |
Recent Tweets for KPTI
 |
@BlueBioNow $KPTI reasonable changes in stock price 2.39 % change recently https://t.co/4qYPkQRo5P 5:07pm |
 |
@GoatInvestments RT @Pharmdca: $KPTI 1) Xpovio approved for MM who failed prior 4 treatments. 2) Xpovio approved for DLBCL for pt’s. 3) Positive Ph3 trial… 2:07pm |
 |
@InTheTrenches2 @BioKaiser @IAmIronManSon $KPTI Dr. Richardson: "...reports from colleagues in NY...at the forefront of the pandem… https://t.co/47Engll4Ms 1:07pm |
|
@InTheTrenches2 @BioKaiser @IAmIronManSon $KPTI Found it (search for paragraph with "Mount Sinai" in it: https://t.co/EzOCkBnmLR 1:07pm |
|
@BlueBioNow $KPTI significant price movement on this stock 2.39 % change recently https://t.co/4qYPkQRo5P 11:07am |
|
@BlueBioNow $KPTI watching closely ... Over $21.68 this rips 2.39 % change recently https://t.co/4qYPkQRo5P 5:07am |
|
@InTheTrenches2 @IAmIronManSon NYC hospital docs noticed that patients on $KPTI ‘s selinexor did better with COVID. Anecdotal, but… https://t.co/JTpWsJcFSz 1:07am |
 |
@Biotech2050 RT @Biotech2050: Worth listening to $KPTI's #COVID19 #Covid_19 trial design webcast https://t.co/Pl0GIidZVK 1:07am |
|
@Biotech2050 RT @Biotech2050: @semodough #3 $KPTI #selinexor #Covid_19 Roper Hospital is just one of 19 sites across the country starting a trial with… 1:07am |
 |
@IAmIronManSon @InTheTrenches2 Why did you tag $KPTI? 1:07am |
 |
@Pharmdca $KPTI 1) Xpovio approved for MM who failed prior 4 treatments. 2) Xpovio approved for DLBCL for pt’s. 3) Positive… https://t.co/ccr5Mvx5yI July 3rd 2020, 8:07pm |
 |
@Tickeron $KPTI in +4.07% Uptrend, growing for three consecutive days on July 2, 2020. View odds for this and other indicator… https://t.co/07AkDjI0UE July 3rd 2020, 7:07pm |
 |
@TroyTiger $IBB. $KPTI - Initiated with an Outperform rating by Morgan Stanley. Also we have a daily Trackdown article with… https://t.co/m5Ba5sMEsT July 3rd 2020, 4:07pm |
 |
@ConsumerFeed Karyopharm Therapeutics $KPTI Coverage Initiated at Morgan Stanley https://t.co/dZZiICqPNR July 3rd 2020, 8:07am |
 |
@dakotafinancial Karyopharm Therapeutics $KPTI Now Covered by Morgan Stanley https://t.co/k3s8EyirXf July 3rd 2020, 8:07am |
 |
@WatchlistN Karyopharm Therapeutics $KPTI Now Covered by Morgan Stanley https://t.co/Mj7ZDRbmcc July 3rd 2020, 8:07am |
|
@BlueBioNow $KPTI This one is getting bipolar : ) 2.39 % change recently https://t.co/4qYPkQRo5P July 3rd 2020, 5:07am |
 |
@WishUponABar @tvinge @Pharmdca Wonder if expecting #Covid19 fail is depressing price $kpti July 2nd 2020, 9:07pm |
 |
@rajramaswamy @Pharmdca FWIW I am adding to both $KPTI and $MYOV later in particular is a clear buy out candidate by sumitomo. July 2nd 2020, 7:07pm |
 |
@stockmktgenius $KPTI Karyopharm Therapeutics I #LeaderPullBack Close: 19.71 Liq: $29M https://t.co/el0QIFVhDg July 2nd 2020, 7:07pm |
 |
@prosperousguy The Float on $KPTI is 43.8M shares w 14.48M Shares Short (Jun 15, 2020) which equates to 33% of the float as Short,… https://t.co/yOfZVCVSg7 July 2nd 2020, 7:07pm |
|
@Tickeron $KPTI in Uptrend: price may jump up because it broke its lower Bollinger Band on June 1, 2020. View odds for this a… https://t.co/5diKlPALCR July 2nd 2020, 6:07pm |
 |
@brockthornhill RT @Pharmdca: Added 3k $KPTI before closing. Going to invest more cash in this company with significant upside as oncology drugs approved a… July 2nd 2020, 5:07pm |
|
@Pharmdca Added 3k $KPTI before closing. Going to invest more cash in this company with significant upside as oncology drugs… https://t.co/THENq6eehz July 2nd 2020, 4:07pm |
 |
@tvinge @Pharmdca @WishUponABar $KPTI ... beyond cheap and they will beat their earnings.. July 2nd 2020, 4:07pm |
 |
@jmbiofarm RT @semodough: MS $KPTI PT 34 Growing Opportunity By Moving Xpovio Earlier in the Treatment Paradigm; Initiate at Overweight-KPTI's Xpovio… July 2nd 2020, 2:07pm |
 |
@YuZhu4 RT @jfais20: $KPTI Morgan Stanley $34PT. Xpovio approved for late line MM & DLBCL. Believes these are "material opportunities," adds that "… July 2nd 2020, 12:07pm |
|
@Biotech2050 RT @Pharmdca: Added more $KPTI July 2nd 2020, 11:07am |
|
@WishUponABar @Pharmdca Do you own a majority of $kpti yet?? July 2nd 2020, 11:07am |
 |
@jfais20 $KPTI Morgan Stanley $34PT. Xpovio approved for late line MM & DLBCL. Believes these are "material opportunities,"… https://t.co/SddDAe7ygK July 2nd 2020, 10:07am |
 |
@darylmox RT @Quantumup1: Morgan Stanley initiates coverage of $KPTI with an Overweight rating, $34 PT https://t.co/aGKZZVR3jR July 2nd 2020, 10:07am |
 |
@PakoRuben RT @pnani456: $KPTI D1 tapping on 20 https://t.co/38ZZn9eMZv July 2nd 2020, 10:07am |
 |
@pnani456 $KPTI D1 tapping on 20 https://t.co/38ZZn9eMZv July 2nd 2020, 10:07am |
 |
@Quantumup1 Morgan Stanley initiates coverage of $KPTI with an Overweight rating, $34 PT https://t.co/aGKZZVR3jR July 2nd 2020, 9:07am |
|
@prosperousguy @semodough Is that $70 $KPTI Bull case in actual writing? July 2nd 2020, 9:07am |
 |
@dantecapital RT @BioStocks: $KPTI initiated at Overweight at Morgan Stanley. PT $34 July 2nd 2020, 9:07am |
|
@Biotech2050 @Karyopharm @US_FDA $KPTI #selinexor #mmsm #myeloma #DLBCL Awaiting #COVID19 #Covid_19 news too July 2nd 2020, 8:07am |
 |
@Anthony_888_ $KPTI Karyopharm initiated with an Overweight at Morgan Stanley with $34 price target July 2nd 2020, 8:07am |
|
@rajramaswamy @BioStocks I have been adding from $18’s Long $KPTI July 2nd 2020, 8:07am |
 |
@haodongvli RT @OlympiaReport: Karyopharm Therapeutics $KPTI Research Coverage Started at Morgan Stanley https://t.co/ENzdE9u135 July 2nd 2020, 8:07am |
 |
@ThomasPhilipp6 RT @thomasmcdanie20: $kpti current price targets. Morgan Stanley new yesterday. Selinexor looks to return to strong growth in 2q through y… July 2nd 2020, 8:07am |
 |
@thomasmcdanie20 @semodough $70 bull case??!! Somebody wants to make some noise $kpti July 2nd 2020, 7:07am |
 |
@semodough MS $KPTI PT 34 Growing Opportunity By Moving Xpovio Earlier in the Treatment Paradigm; Initiate at Overweight-KPTI'… https://t.co/t0ivaiL4ER July 2nd 2020, 7:07am |
 |
@OxAnalyst @avidresearch Like $KPTI long-term but it’s been a potato despite approval July 2nd 2020, 7:07am |
 |
@BioStocks $KPTI initiated at Overweight at Morgan Stanley. PT $34 July 2nd 2020, 7:07am |
|
@thomasmcdanie20 $kpti current price targets. Morgan Stanley new yesterday. Selinexor looks to return to strong growth in 2q throug… https://t.co/3c8V04qotS July 2nd 2020, 7:07am |
 |
@BioKaiser RT @stockhoot: $KPTI Morgan Stanley Initiates Coverage On to Overweight : PT $34.00 https://t.co/Ia7veJr19I July 2nd 2020, 7:07am |
 |
@stockhoot $KPTI Morgan Stanley Initiates Coverage On to Overweight : PT $34.00 https://t.co/Ia7veJr19I July 2nd 2020, 5:07am |
|
@ThomasPhilipp6 RT @sbwcws: Karyopharm initiated with an Overweight at Morgan Stanley $KPTI July 2nd 2020, 2:07am |
|
@darylmox RT @WeekHerald: Karyopharm Therapeutics $KPTI Research Coverage Started at Morgan Stanley https://t.co/DZhgS4iBaN July 1st 2020, 7:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
